- £123.19m
- £117.00m
- £38.44m
Brief: Diaceutics Says Q1 2026 Performance In Line With Board's Expectations
Final Results
Notice of Results
Holding(s) in Company
PDMR Shareholding/Share Incentive Plan and TVRs
PDMR Shareholding/SIP & Total Voting Rights
PDMR Shareholding/Share Incentive Plan and TVRs
Brief: Diaceutics Expects To Deliver 25% Revenue Growth In FY26
Full Year 2025 Trading Update
PDMR Shareholding/SIP & Total Voting Rights
PDMR Shareholding/Share Incentive Plan and TVR
Brief: Diaceutics H1 Pretax Profit GBP -3.013 Million
H1 2025 Results
Notice of Results
Holding(s) in Company
PDMR Shareholding/Share Incentive Plan and TVR
Holding(s) in Company
Diaceutics at Canaccord Genuity Growth Conference
Diaceutics Announces Key Leadership Appointment